These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24382178)

  • 1. Comparison of changes in the percentages of CD8+CD28-TCRalpha beta+ T cell subpopulations in allergic asthma subjects vs controls before and after anti-CD3/anti-CD28/IL-2 stimulation in vitro.
    Eusebio M; Kraszula L; Kupczyk M; Kuna P; Pietruczuk M
    J Biol Regul Homeost Agents; 2013; 27(4):969-79. PubMed ID: 24382178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of interleukin-10 or TGF-beta on anti-CD3/CD28 induced activation of CD8+CD28- and CD8+CD28+ T cells in allergic asthma.
    Eusebio M; Kraszula L; Kupczyk M; Kuna P; Pietruczuk M
    J Biol Regul Homeost Agents; 2013; 27(3):681-92. PubMed ID: 24152837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergy-related changes in levels of CD8+CD25+FoxP3(bright) Treg cells and FoxP3 mRNA expression in peripheral blood: the role of IL-10 or TGF-beta.
    Eusebio M; Kuna P; Kraszula L; Kupczyk M; Pietruczuk M
    J Biol Regul Homeost Agents; 2014; 28(3):461-70. PubMed ID: 25316133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
    Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR
    Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells.
    Sung JL; Lin JT; Gorham JD
    Int Immunopharmacol; 2003 Feb; 3(2):233-45. PubMed ID: 12586604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of CD28 costimulation in human CD8+ T cells.
    Lloyd TE; Yang L; Tang DN; Bennett T; Schober W; Lewis DE
    J Immunol; 1997 Feb; 158(4):1551-8. PubMed ID: 9029089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads.
    Teschner D; Wenzel G; Distler E; Schnürer E; Theobald M; Neurauter AA; Schjetne K; Herr W
    Scand J Immunol; 2011 Aug; 74(2):155-64. PubMed ID: 21517928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics and proliferative capacities of CD8
    Pietruczuk M; Kraszula L; Kupczyk M; Kuna P; Eusebio M
    J Biol Regul Homeost Agents; 2021; 35(2):485-494. PubMed ID: 33985326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
    Chen FL; Kung JT
    J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate and function of anti-CD3/CD28-activated T cells following adoptive transfer: IL-2 promotes development of anti-tumor memory T cells in vivo.
    Hughes DP; Baskar D; Urban FF; Friedman MS; Braun TM; McDonagh KT
    Cytotherapy; 2005; 7(5):396-407. PubMed ID: 16236629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulatory function of umbilical cord blood CD4(+) CD25(+) T cells stimulated with anti-CD3/anti-CD28 and exogenous interleukin (IL)-2 or IL-15.
    Lee CC; Lin SJ; Cheng PJ; Kuo ML
    Pediatr Allergy Immunol; 2009 Nov; 20(7):624-32. PubMed ID: 19302176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4.
    Pollok KE; Kim SH; Kwon BS
    Eur J Immunol; 1995 Feb; 25(2):488-94. PubMed ID: 7875212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
    Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
    J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK; Doyle LV
    J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response.
    Leite-de-Moraes MC; Herbelin A; Machavoine F; Vicari A; Gombert JM; Papiernik M; Dy M
    J Immunol; 1995 Nov; 155(10):4544-50. PubMed ID: 7594451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.